Prince Talal honours winners of 2026 King Hussein Cancer Research Award
14/11/2026 | 23:48:38
`` Amman, November 14 (Petra) – Representing His Majesty King Abdullah II, His Royal Highness Prince Talal bin Muhammad honoured the winners of the 2026 King Hussein Cancer Research Award.
The winners were honoured at a ceremony attended by Her Royal Highness Princess Ghida Talal, Chairperson of the Board of Trustees of the King Hussein Cancer Foundation and Center and several members of the Royal Family.
In her address, Princess Ghida praised the Arab researchers for their contributions to cancer research and their efforts to advance scientific discoveries and improve patient care.
The award recognises outstanding contributions to cancer research, encourages the development of improved prevention and treatment methods and promotes regional and international scientific collaboration.
This year's ceremony recognised researchers selected from hundreds of applicants representing more than 26 countries. Nizar Tannir of the University of Texas MD Anderson Cancer Center received the Special Excellence in Scientific Research Award, while Amer Zeidan of Yale Comprehensive Cancer Center received the International Lifetime Achievement Award.
Imam Waked of Menoufia University received the Regional Lifetime Achievement Award.
The Emerging Researcher Awards went to Maryam Shalaby of the Netherlands Cancer Institute (International Track) and Omnia Atallah of the Arab Academy for Science, Technology and Maritime Transport (Regional Track).
The Promising Researcher Grants were awarded to Zaid Abdul Rahman of the King Hussein Cancer Center and Philip Hussein Qobeissi of the Lebanese American University.
The center's Bone Marrow Transplant, Cellular Therapy, and CAR-T Cell Therapy Programme also received the Professional Development Programme Award for Excellence in Cancer Patient Care.
Launched in 2020 in memory of the late King Hussein bin Talal, the award aims to strengthen Arab cancer research and support scientific efforts to improve cancer prevention and treatment.
Since its establishment, it has received more than 950 applications from over 30 countries, evaluated by international experts.
//Petra// AK